Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
THOMAS ALBINI
Listed Specialty: Ophthalmology
900 NW 17TH ST, BOX 025809, MIAMI, FL, 33136-1119
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
DR. THOMAS ALBINI,
Yearly Payment Breakdown:
2018 Payments At a Glance
57
payments
$30,481
payment total
10
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
4 | $20,755 |
Nonaccredited Training |
1 | $5,250 |
Food and Beverage |
43 | $3,087 |
Travel and Lodging |
8 | $1,250 |
Promotional Speaking/Other |
1 | $139 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
RETISERT |
drug |
$12,720 |
VISUDYNE |
drug |
$6,725 |
LUCENTIS |
drug |
$5,016 |
ILEVRO |
drug |
$4,268 |
OZURDEX |
drug |
$619 |
Payments with no listed product |
N/A |
$350 |
FORESEEHOME |
device |
$349 |
EYLEA |
drug |
$156 |
ACTHAR |
drug |
$148 |
LOTEMAX |
drug |
$102 |
RESURE SEALANT |
device |
$28 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Feb 23, 2018 | $6,405 | VISUDYNE | Consulting | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 18, 2018 | $6,000 | RETISERT | Consulting | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 24, 2018 | $5,250 | RETISERT | Nonaccredited Training | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Mar 22, 2018 | $4,200 | ILEVRO | Consulting | NOVARTIS PHARMACEUTICALS CORPORATION | |
| Jul 20, 2018 | $4,150 | LUCENTIS | Consulting | GENENTECH USA, INC. | |
| Oct 11, 2018 | $383 | RETISERT | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 11, 2018 | $314 | RETISERT | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 11, 2018 | $232 | RETISERT | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Feb 23, 2018 | $200 | VISUDYNE | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 29, 2018 | $150 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| May 10, 2018 | $139 | FORESEEHOME | Promotional Speaking/Other | NOTALVISION | |
| Jul 20, 2018 | $128 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Apr 11, 2018 | $124 | ACTHAR | Food and Beverage | MALLINCKRODT LLC | |
| Sep 11, 2018 | $122 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Mar 20, 2018 | $120 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Jul 20, 2018 | $120 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jan 19, 2018 | $118 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Jan 16, 2018 | $117 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Jan 16, 2018 | $117 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Mar 8, 2018 | $112 | FORESEEHOME | Food and Beverage | NOTALVISION | |
| Dec 19, 2018 | $112 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Feb 10, 2018 | $109 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Jan 13, 2018 | $107 | No Listed Product | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 21, 2018 | $106 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jan 15, 2018 | $105 | EYLEA | Food and Beverage | REGENERON PHARMACEUTICALS, INC. | |
| Jan 17, 2018 | $104 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
| May 24, 2018 | $102 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Aug 22, 2018 | $98 | FORESEEHOME | Food and Beverage | NOTALVISION | |
| Feb 9, 2018 | $94 | LUCENTIS | Food and Beverage | GENENTECH, INC. | |
| Oct 25, 2018 | $88 | No Listed Product | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Nov 29, 2018 | $80 | LOTEMAX | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Nov 28, 2018 | $71 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 23, 2018 | $69 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Mar 22, 2018 | $68 | ILEVRO | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
| Feb 23, 2018 | $65 | VISUDYNE | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 21, 2018 | $61 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 27, 2018 | $53 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Oct 27, 2018 | $53 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
| Jul 21, 2018 | $33 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Jul 23, 2018 | $31 | OZURDEX | Food and Beverage | ALLERGAN INC. | |
| Mar 20, 2018 | $30 | LUCENTIS | Food and Beverage | GENENTECH, INC. | |
| Jan 15, 2018 | $28 | RESURE SEALANT | Food and Beverage | OCULAR THERAPEUTIX, INC. | |
| Mar 22, 2018 | $28 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Jul 22, 2018 | $27 | EYLEA | Food and Beverage | REGENERON HEALTHCARE SOLUTIONS, INC. | |
| Jan 2, 2018 | $26 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 22, 2018 | $24 | EYLEA | Food and Beverage | REGENERON HEALTHCARE SOLUTIONS, INC. | |
| Jul 9, 2018 | $24 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 3, 2018 | $24 | ACTHAR | Food and Beverage | MALLINCKRODT LLC | |
| Oct 11, 2018 | $21 | LOTEMAX | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Oct 16, 2018 | $21 | RETISERT | Food and Beverage | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Feb 23, 2018 | $20 | VISUDYNE | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Feb 9, 2018 | $19 | LUCENTIS | Food and Beverage | GENENTECH, INC. | |
| Feb 23, 2018 | $19 | VISUDYNE | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jan 15, 2018 | $17 | LUCENTIS | Food and Beverage | GENENTECH USA, INC. | |
| Jul 22, 2018 | $17 | LUCENTIS | Food and Beverage | GENENTECH, INC. | |
| Feb 23, 2018 | $16 | VISUDYNE | Travel and Lodging | BAUSCH & LOMB, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Jul 23, 2018 | $14 | OZURDEX | Food and Beverage | ALLERGAN INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.